guilherme henrique espíndola efeitos adversos dos ... - UFSC

REFERÊNCIAS BIBLIOGRÁFICAS1. Programa Nacional de DST e Aids – Guia de Tratamento Clínico da Infecção peloHIV em crianças. Brasília/DF – 2004.2. Sharland M, Blanche S, Castelli G, Ramos J and Gibb DM on behalf of the PENTASteering Committee. 2004 British HIV Association. HIV Medicine I , 5, 61-86.3. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV infection, disponívelem: www.aidsinfo.nih.gov . Acessado em 24 de setembro de 2004.4. Palella FJ Jr., Delaney KM, Moorman AC, Loveless MO, Fuhre J, Satten GA, et al.Declining morbidity and mortality among patients within advanced humanimmunodeficiency vírus infection. HIV Outpatient Study Investigators. N Engl. J Méd1998;338: 853-60.5. Montessori V, Press N, Harris M, Akagi L, Montaner JSG. Adverse effects ofantiretroviral therapy for HIV infection. CMAJ 2004 Jan 20;170 (2):6. British HIV Association HIV Medicine (2004) 5 (Suppl. 2), 61-86.7. Carr A. HIV, Improvement of the study, analysis, and reporting of adverse eventsassociated with antiretroviral therapy. Lancet 2002;360: 81-5.8. US Food and Drug Administration. Managing the risk from medical product use:creating a risk management framework. http://www.fda.gov/oc/tfrm/1999report.html(acessado em Maio 28, 2002)9. d’Arminio Monforte A, Lepri, AC, Rezza G, Pezzotti P, Antinori A, PhillipsAN, etal.Insights into the reasons for discontinuation of the first Highly antiretroviral ActiveTherapy (HAART) regimen in a cohort of antiretroviral naive patients. AIDS 2000;14:499-507.10. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a largeurban clinic: risk and factors for virologic failure and adverse drug reactions. Ann InternMéd 1999;131: 81-7.11. Wallach J, M.D. Interpretation of Diagnostic Tests – Seventh edition. 2000 VolumeÚnico; página 10.